Novel piperidines as chemokine modulators (CCR)

Details for Australian Patent Application No. 2005207817 (hide)

Owner AstraZeneca AB

Inventors Furber, Mark; Luckhurst, Christopher; Cage, Peter; Rigby, Aaron; Kinchin, Elizabeth; Alcaraz, Lilian

Agent Freehills

Pub. Number AU-B-2005207817

PCT Pub. Number WO2005/073192

Priority 0400208-5 02.02.04 SE

Filing date 31 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 24 July 2008

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4523 (2006.01) - containing further heterocyclic ring systems

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/073192 Priority application(s): WO2005/073192

24 July 2008 Application Accepted

  Published as AU-B-2005207817

20 November 2008 Standard Patent Sealed

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207821-Selective estrogen receptor modulators for the treatment of vasomotor symptoms

2005207816-HCV NS-3 serine protease inhibitors